2016
DOI: 10.1136/ejhpharm-2016-000915
|View full text |Cite
|
Sign up to set email alerts
|

A systematic review of approaches for calculating the cost of medication errors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
15
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(24 citation statements)
references
References 28 publications
(48 reference statements)
0
15
0
Order By: Relevance
“…Quality of life was not considered in any of the included studies. This is in keeping with the findings of a recent review conducted by Patel et al of approaches used for calculating the cost of medication errors . In addition, the costs explored from a primary care perspective were limited, and costs pertaining to time of general practitioners and pharmacists were absent.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Quality of life was not considered in any of the included studies. This is in keeping with the findings of a recent review conducted by Patel et al of approaches used for calculating the cost of medication errors . In addition, the costs explored from a primary care perspective were limited, and costs pertaining to time of general practitioners and pharmacists were absent.…”
Section: Discussionmentioning
confidence: 99%
“…Greater detail is also required from an economic perspective. Clear descriptions of cost sources and explicit cost calculations are required as recommended by Patel et al in their recent review of approaches for calculating the cost of medication errors . Additionally, the timeframe during which the costs are calculated should be specified.…”
Section: Discussionmentioning
confidence: 99%
“…Although the methods used in the studies of the economic impact of ADEs have been reviewed [1,2], there is no consensus or "criterion standard" for how costs resulting from ADEs should be measured. According to a recent review of the literature [20], this difficulty in assigning resource use and costs to specific events applies also to studies of medication errors (i.e., avoidable harm resulting from drug therapy). The identification of resource use [12], the resource use resulting from ADEs was identified using an assessment scheme ( Table 2) and costs were included as all costs if dominant association, half the cost if partly contributing, and one-third of the cost if less contributing to a health care encounter.…”
Section: Discussionmentioning
confidence: 99%
“…This study demonstrated the intervention could be considered cost-effective as outlined by the break-even analysis reported in more detail in Appendix C. Making sense of cost-effectiveness in a healthcare professions education context is complicated. 65,66 With respect to this study, the analysis was approached by comparing the cost of the intervention to an average cost for a medication error in the first study. Clearly the costs and benefits will vary across different sub-specialty contexts.…”
Section: T a B L Ementioning
confidence: 99%